FNDC5 and myocardial infarction: Previous studies demonstrated that irisin/FNDC5 significantly inhibited cardiomyopathic hypertrophy, reduced cell apoptosis and alleviated myocardial fibrosis, and ultimately improved cardiac function in MI model [30,31,32].